Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Immunology. Found 9 abstracts

Beauchemin L, Slifker M, Rossell D, Font-Burgada J. Characterizing MHC-I Genotype Predictive Power for Oncogenic Mutation Probability in Cancer Patients. Methods Mol Biol. 2020 Jan;2131:185-98.
Kong WM, Li HB, Tuma RF, Ganea D. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS. Cell Immunol. 2014 Jan;287(1):1-17.
Nishimori JH, Newman TN, Oppong GO, Rapsinski GJ, Yen JH, Biesecker SG, Wilson RP, Butler BP, Winter MG, Tsolis RM, Ganea D, Tukel C. Microbial Amyloids Induce Interleukin 17A (IL-17A) and IL-22 Responses via Toll-Like Receptor 2 Activation in the Intestinal Mucosa. Infect Immun. 2012 Dec;80(12):4398-408.
Ciofani M, Knowles GC, Wiest DL, von Boehmer H, Zuniga-Pflucker JC. Stage-specific and differential notch dependency at the alpha beta and gamma delta T lineage bifurcation. IMMUNITY. 2006 Jul;25(1):105-16.
Klumpp TR, Herman J, Ulicny J, Emmons RV, Martin ME, Mangan KF. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. BONE MARROW TRANSPLANTATION. 2006 Nov;38(9):615-20.
Rumfelt LL, Zhou Y, Rowley BM, Shinton SA, Hardy RR. Lineage specification and plasticity in CD19(-) early B cell precursors. JOURNAL OF EXPERIMENTAL MEDICINE. 2006 Mar;203(3):675-87.
Scallon BJ, Snyder LA, Anderson GM, Chen QM, Yan L, Weiner LM, Nakada MT. A review of antibody therapeutics and antibody-related technologies for oncology. JOURNAL OF IMMUNOTHERAPY. 2006 Jul;29(4):351-64.
Tong X, Yin L, Joshi S, Rosenberg DW, Giardina C. Cyclooxygenase-2 regulation in colon cancer cells: Modulation of RNA polymerase II elongation by histone deacetylase inhibitors. Journal of Biological Chemistry. 2005 Jan;280(16):15503-9.
Hardy RR. B Lymphocyte development and biology. In: Paul WE, editor. Fundamental Immunology. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 159-94.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Immunology

Immunology Research & Experimental Medicine expression Oncology differentiation human t-cells Cells Infectious Diseases Drug products clinical-trials publication bias Cancer susceptibility prediction APOPTOSIS identification bone-marrow-transplantation Chemokines hematopoietic stem cell transplantation cell-development Major histocompatibility complex (MHC) thymocyte differentiation Carcinogens mice Transplantation GAMMA-INTERFERON PRODUCTION ESCHERICHIA-COLI RECEPTORS Butyrate cyclooxygenase 2 hematopoietic stem-cells common lymphoid progenitors in-vivo versus-host-disease DIRECT SUPPRESSION rearrangement Colon carcinogenesis AGONIST in-vitro transcription HUMAN T-LYMPHOCYTES Immunity Cancer predisposition EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS MULTIPLE-SCLEROSIS T-CELLS Neoantigens antitumor-activity pre-tcr gamma-delta incompatibility lymphopoiesis human igg1 regeneration survival Neoplastic Gene Expression Regulation Cell Biology CURLI LEGIONELLA-PNEUMOPHILA INFECTION Immunoediting Hematology Human leukocyte antigen (HLA) IN-VIVO Gp1a selection complement activation ENTERICA SEROTYPE TYPHIMURIUM severe aplastic-anemia Cannabinoid receptor anti-cd20 monoclonal-antibody INFLAMMATORY BOWEL DISEASES SEROVAR TYPHIMURIUM fate EAE hpc transplantation CUTTING EDGE DENDRITIC CELLS colon cancer graft-versus-host disease fate specification Tumor necrosis factor (TNF) ABO system Th17 differentiation mouse bone-marrow Colon cancer cells fc-gamma-ri CENTRAL-NERVOUS-SYSTEM necrosis-factor-alpha thiol reductase gilt Cancer Bioassay thymic development SALMONELLA-TYPHIMURIUM risk-factors Antigen presentation Immunotherapy dependent cellular cytotoxicity beta CANNABINOID FIBERS Precipitation (chemical) RNA
Last updated on Sunday, July 05, 2020